According to Thomson Reuters' Journal Citation Report® (JCR; Clarivate Analytics 2017), publications from the American Association for Cancer Research (AACR) continue to be rated among the most influential journals in cancer research and medicine. The entire portfolio of AACR journals, which represent 3.7% of the 217 journals in the Oncology category, garnered 15.5% of all citations in the same category. One half of the AACR journals rank in the top 8% in regard to Impact Factor in the Oncology category. Cancer Discovery ranks 7th in the Oncology category, with its fourth Impact Factor (20.011). Clinical Cancer Research ranks 12th in the Oncology category with an Impact Factor of 9.619 and Cancer Research's Impact Factor of 9.122, ranks the journal in 15th in the Oncology category. The Impact Factor for Cancer Immunology Research increased over 24%, to 8.284, compared to the previous year.
Impact Factor:
As reported in the most recent release of the JCR, four of the eight AACR journals rank in the top 8% of oncology journals with regard to Impact Factor.
|
Journal |
Impact Factor |
Rank (of 217 Oncology Journals) |
|---|---|---|
| Cancer Discovery | 20.011 | 7 |
| Cancer Epidemiology, Biomarkers & Prevention | 4.142 | 63 24 of 176 Public Health journalsa |
| Cancer Immunology Research | 8.284 | 17 13 of 150 Immunology journals |
| Cancer Prevention Research | 3.985 | 67 |
| Cancer Research | 9.122 | 15 |
| Clinical Cancer Research | 9.619 | 12 |
| Molecular Cancer Research | 4.974 | 49 |
| Molecular Cancer Therapeutics | 5.764 | 36 |
|
aCancer Epidemiology, Biomarkers & Prevention is also ranked in the Public, Environmental and Occupational Health category in JCR. |
||
Five-Year Impact Factor:
While the standard Impact Factor measures citations to journal articles published within a 2-year period, the 5-year Impact Factor evaluates citations to journal articles published within a 5-year period to provide a measure of a journal's longer-term influence. AACR journals are all in the top 23% among Oncology journals with respect to 5-year Impact Factor. In addition, Cancer Discovery, Cancer Research, and Clinical Cancer Research rank within the top 6% in the Oncology category for 5-year Impact Factor.
|
Journal |
Five-Year |
Rank (of 217 Oncology Journals) |
|---|---|---|
| Cancer Discovery | 22.342 | 5 |
| Cancer Epidemiology, Biomarkers & Prevention | 4.202 | 50 27 of 176 Public Health journalsa |
| Cancer Immunology Research | 8.647 | 17 |
| Cancer Prevention Research | 4.391 | 59 |
| Cancer Research | 9.826 | 11 |
| Clinical Cancer Research | 9.250 | 14 |
| Molecular Cancer Research | 5.041 | 44 |
| Molecular Cancer Therapeutics | 6.163 | 28 |
|
aCancer Epidemiology, Biomarkers & Prevention is also ranked in the Public, Environmental and Occupational Health category in JCR. |
||
Eigenfactor:
The Eigenfactor uses methods from network theory to rank the influence of journals, much as Google's PageRank algorithm ranks the influence of web pages, by identifying journals as influential if they are cited often by other influential journals. Seven of the eight AACR journals are ranked in the top 23% of Oncology journals by Eigenfactor. Cancer Research and Clinical Cancer Research rank 2nd and 3rd, respectively, by Eigenfactor in the Oncology category.
|
Journal |
Eigenfactor |
Rank (of 217 Oncology Journals) |
|---|---|---|
| Cancer Discovery | 0.05345 | 18 |
| Cancer Epidemiology, Biomarkers & Prevention | 0.03344 | 26 12 of 176 Public Health journalsa |
| Cancer Immunology Research | 0.01391 | 63 |
| Cancer Prevention Research | 0.01557 | 55 |
| Cancer Research | 0.14918 | 2 |
| Clinical Cancer Research | 0.14099 | 3 |
| Molecular Cancer Research | 0.01646 | 53 |
| Molecular Cancer Therapeutics | 0.03361 | 26 |
|
aCancer Epidemiology, Biomarkers & Prevention is also ranked in the Public, Environmental and Occupational Health category in JCR. |
||
Immediacy Index:
An Immediacy Index is a measure of how topical and urgent work published in a scientific journal is. The Immediacy Index is calculated by dividing the number of citations to articles published in a given year by the number of articles published in that year. Six of the eight AACR journals rank in the top 20% in terms of Immediacy Index. Cancer Discovery, Cancer Research, and Clinical Cancer Research rank in the top 20 of the 213 journals in the Oncology category.
|
Journal |
Immediacy Index |
Rank (of 217 Oncology Journals) |
|---|---|---|
| Cancer Discovery | 6.134 | 5 |
| Cancer Epidemiology, Biomarkers & Prevention | 1.167 | 36 22 of 176 Public Health journalsa |
| Cancer Immunology Research | 1.696 | 22 |
| Cancer Prevention Research | 0.939 | 56 |
| Cancer Research | 1.745 | 19 |
| Clinical Cancer Research | 2.605 | 11 |
| Molecular Cancer Research | 0.982 | 52 |
| Molecular Cancer Therapeutics | 0.868 | 60 |
|
aCancer Epidemiology, Biomarkers & Prevention is also ranked in the Public, Environmental and Occupational Health category in JCR. |
||
American Association for Cancer Research
615 Chestnut Street | 17th Floor | Philadelphia, PA 19106-4404
Phone: (215) 440-9300 | Fax: (215) 440-9354 | E-mail: pubs@aacr.org